| PERIOD ENDING | 31-Jul-09 | 31-Jul-08 | 31-Jul-07 | | Total Revenue | 728 | 1,487 | 336 | | Cost of Revenue | 238 | 464 | 221 | | | Gross Profit | 490 | 1,024 | 115 | | | Operating Expenses | | Research Development | 1,468 | 1,646 | 1,221 | | Selling General and Administrative | 6,156 | 5,949 | 3,735 | | Non Recurring |
-
| 109 |
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (7,134) | (6,680) | (4,841) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 70 | 142 | 188 | | Earnings Before Interest And Taxes | (7,065) | (6,538) | (4,652) | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | (7,065) | (6,538) | (4,652) | | Income Tax Expense | 2 | 2 | 2 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (7,067) | (6,540) | (4,655) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (7,067) | (6,540) | (4,655) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($7,067) | ($6,540) | ($4,655) |
|
0.11% Nasdaq 0.00%
Income Statement
